VALENCIA, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (RCEL) (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound ...
AVITA Medical (RCEL) “announced that the FDA has granted 510(k) clearance for Cohealyx, a new collagen-based dermal matrix branded by AVITA Medical and co-developed with Regenity Biosciences. Cohealyx ...
Acquisition expands Bimini's global soft tissue franchise, which already includes the PureGraft and Dermapose Fat Transfer Systems PLANO, Texas, March 28, 2023 /PRNewswire/ -- Bimini Health Tech ...
Please provide your email address to receive an email when new articles are posted on . Regenity will cover manufacturing and Avita will lead marketing and distribution. The product generates a dermal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results